FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Zygmont Chester Stanley III		 2. Date of Event Requiring Statement (MM/DD/YYYY)
1/10/2022 

 3. Issuer Name and Ticker or Trading Symbol

REVELATION BIOSCIENCES, INC. [REVB]
(Last)        (First)        (Middle)

C/O REVELATION BIOSCIENCES, INC., 4660 LA JOLLA VILLAGE DR., SUITE 100		 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Chief Financial Officer /
(Street)

SAN DIEGO, CA 92122      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		2. Amount of Securities Beneficially Owned
(Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 463285 I By Trust (1)
Common Stock 218017 I By LLC (2)
Common Stock 2144 I By Spouse (3)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit  (4) (5)Common Stock 6853  (6)D  
Restricted Stock Unit  (7) (5)Common Stock 15588  (6)D  
Explanation of Responses:
(1) Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee.
(2) Shares are held by Czeslaw Capital Fund, LLC. Chester S Zygmont III is the sole manager of Czeslaw Capital Fund, LLC.
(3) The Reporting Person disclaims beneficial ownership of shares held by the Reporting Person's spouse directly.
(4) These RSUs vest 25% on January 31, 2021, and thereafter quarterly over a three-year period.
(5) RSUs do not expire; they either vest or are canceled prior to vesting date.
(6) Each RSU converts into common stock on a one-for-one basis.
(7) These RSUs vest 25% on February 23, 2022, and thereafter monthly over a three-year period.

Remarks:
Exhibit 24 - Power of Attorney.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Zygmont Chester Stanley III
C/O REVELATION BIOSCIENCES, INC.
4660 LA JOLLA VILLAGE DR., SUITE 100
SAN DIEGO, CA 92122

Chief Financial Officer
Signatures
/s/ J.P. Galda, as attorney-in-fact for Chester S Zygmont, III1/20/2022
**Signature of Reporting PersonDate
Petra Acquisition (NASDAQ:PAIC)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Petra Acquisition.
Petra Acquisition (NASDAQ:PAIC)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Petra Acquisition.